Covance Inc

Type: Company
Name: Covance Inc
Nationality: United States
Web Address: http://www.covance.com/
Fact Sheet: Fact Sheet for Covance Inc
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Covance (CVD) Showing Bearish Technicals

Covance Inc (CVD) presents a trading opportunity that offers a 7% return in just 53 days.A covered call on Covance at the $85.00 level expiring on Nov. '14 offers an assigned return rate of 7% or 48.20% annualized. This trade offers 1.30% downside protection, ... [Published MarketIntelligenceCenter.com - 6 hours ago]
Entities: Covance Inc
First reported Sep 17 2014 - Updated Sep 18 2014 - 1 reports

Covance Inc. And Frenova Renal Research Establish Innovative Research Collaboration

Researchers Will Share and Analyze Data to Improve Lives of Patients LivingWith Chronic Kidney Disease and End Stage Renal Disease(Princeton, N.J., and Waltham, Mass., (September 17, 2014) — Covance Inc. (NYSE: CVD), a leading global drug development ... [Published BioSpace - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 17 2014 - 2 reports

Covance Down 13.7% Since SmarTrend Downtrend Call (CVD)

Written on Tue, 09/16/2014 - 6:29pmBy Shiri GuptaSmarTrend identified a Downtrend for Covance ( NYSE:CVD ) on April 7th, 2014 at $98.69. In approximately 5 months, Covance has returned 13.73% as of today's recent price of $85.14.Covance share prices ... [Published Comtex SmarTrend - Sep 17 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Covance (CVD) Showing Support Near $84.71

The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Covance Inc (CVD) that includes 1.78% downside protection. Sell one contract of the Nov. '14 $90.00 ... [Published MarketIntelligenceCenter.com - Sep 12 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Insider Selling: Joseph L. Herring Unloads 32,200 Shares of Covance Stock (CVD)

Covance (NYSE:CVD) CEO Joseph L. Herring sold 32,200 shares of Covance stock on the open market in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $85.13, for a total value of $2,741,186.00. Following ... [Published American Banking News - Forex - Sep 11 2014]
First reported Sep 09 2014 - Updated Sep 10 2014 - 2 reports

Covance (CVD) Trading Near $83.84 Support Level

A covered call identified by MarketIntelligececenter.com's patented algorithm on Covance Inc (CVD) could yield about 3.84% (19.18% annualized, for comparison purposes only) in 73 days. Pair a long position in the stock with the Nov. '14 $85.00 call for ... [Published MarketIntelligenceCenter.com - Sep 10 2014]
First reported Sep 07 2014 - Updated Sep 08 2014 - 3 reports

Covance To Present At The Morgan Stanley Global Healthcare Conference

PRINCETON, N.J.Covance, the world's most comprehensive drug development company and a leader in nutritional analysis, is dedicated to advancing healthcare and delivering Solutions Made Real™Statements contained in this press release, which are not historical ... [Published Stock Nod - Sep 07 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Covance (CVD) Showing Resistance Near $85.41

Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Covance Inc (CVD) that should provide a 3.48% return in just 78 days. Sell one Nov. '14 call at the $85.00 level for each 100 shares of Covance for ... [Published MarketIntelligenceCenter.com - Sep 05 2014]
Entities: Covance Inc, Patent
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Covance (CVD) Sells Antibody Services Unit to BioLegend

New Jersey-based drug development services company Covance Inc. ( CVD - Analyst Report ) recently divested its antibody services unit to antibodies and reagents developer and manufacturer BioLegend, Inc. However, financial terms of the deal were un ... [Published Zacks.com - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 2 reports

BioLegend Acquires Antibody Products Business Unit From Covance

San Diego-based BioLegend Inc. acquired the shares of Covance Antibody Services Inc., a business unit of Massachusetts-based Covance Inc., on August 29.The Covance Antibody business unit develops and manufactures antibodies and research reagents for neuroscience, ... [Published San Diego Business Journal - Sep 02 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 2 reports

Covance Has Returned 15.9% Since SmarTrend Recommendation (CVD)

Written on Tue, 09/02/2014 - 12:48pmBy James QuinnSmarTrend identified a Downtrend for Covance ( NYSE:CVD ) on April 7th, 2014 at $98.68. In approximately 5 months, Covance has returned 15.93% as of today's recent price of $82.96.In the past 52 weeks, ... [Published Comtex SmarTrend - Sep 02 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 2 reports

Covance Retains Balanced View on Steady Growth

we issued an updated research report on Covance Inc. ( CVD - Analyst Report ). Covance has managed to post healthy second-quarter results with earnings beat and in-line revenues on healthy year-over-year growth across both its segments.Adjusted earnings ... [Published Zacks.com - Aug 22 2014]

Quotes

"The SEC knows that it has serious weaknesses in its case, and that is why it is choosing to bring this as an administrative proceeding instead of trying this case in a federal court" he said
...members Jane Okun Bomba and Ruth Cotter for their extraordinary contributions while serving on the board the past four years," Donohue continued. "I encourage members to actively participate in local chapter and national activities so that together, we can advance the NIRI organization and profession."
"The addition of Neuroscience and IHC antibody tools to our catalog means accelerated discovery for our current and new customers. We also hope to bring our well-known quality, support, and value in the Immunology community to Neuroscience researchers world-wide" said Lay
Zacks’ analyst wrote, "Covance reported a decent second-quarter 2014, with adjusted EPS of $0.95, which was up 21.8% year over year and ahead of the Zacks Consensus Estimate by $0.02. Revenues were up 8% at $639.5 million, inline with the Zacks Consensus Estimate. Despite increased spending on strategic IT projects, Late-Stage Development continues to grow strongly on the back of better-than-estimated kit volumes in central laboratories and strong performance of Phase II-IV clinical development services. Moreover, after several quarters of drag, Early Development started showing signs of recovery with improvement in clinical pharmacology and toxicology. Although capital spending environment and competitive landscape remain as overhangs, we believe Covance is positioned well to drive growth in the coming quarters. However, the expiry of Sanofi deal in 2015 is a major concern. Currently, we are Neutral on the stock."

More Content

All (175) | News (30) | Reports (0) | Blogs (137) | Audio/Video (0) | Fact Sheets (2) | Press Releases (6)
sort by: Date | Relevance
SEC Charges Ex Wells Fargo Analysts With Inside... [Published Value Walk - 5 hours ago]
Covance (CVD) Showing Bearish Technicals [Published MarketIntelligenceCenter.com - 6 hours ago]
U.S. charges ex-Wells Fargo employees with insi... [Published Yahoo! Maktoob News - 22 hours ago]
Covance (CVD) Showing Bearish Technicals With S... [Published MarketIntelligenceCenter.com - Sep 29 2014]
Covance (CVD) Trading Near $81.68 Support Level [Published MarketIntelligenceCenter.com - Sep 26 2014]
Impax Laboratories : Mark Donohue Elected as Ne... [Published 4 Traders - Sep 26 2014]
Covance (CVD) Trading Near $84.72 Resistance Level [Published MarketIntelligenceCenter.com - Sep 25 2014]
Biggest Movers in Healthcare Stocks Now – ACOR ... [Published InvestorPlace.com - Sep 24 2014]
Covance (CVD) Showing Bearish Technicals With R... [Published MarketIntelligenceCenter.com - Sep 24 2014]
Covance (CVD) Showing Neutral Technicals With R... [Published MarketIntelligenceCenter.com - Sep 23 2014]
Potential Covance (CVD) Trade Has 1.35% Downsid... [Published MarketIntelligenceCenter.com - Sep 22 2014]
Covance (CVD) Showing Bullish Technicals With S... [Published MarketIntelligenceCenter.com - Sep 19 2014]
Covance (CVD) Trading Near $83.52 Support Level [Published MarketIntelligenceCenter.com - Sep 18 2014]
Covance Inc. And Frenova Renal Research Establi... [Published BioSpace - Sep 17 2014]
Biggest Movers in Healthcare Stocks Now – AUXL ... [Published InvestorPlace.com - Sep 17 2014]
Covance (CVD) Showing Bearish Technicals With R... [Published MarketIntelligenceCenter.com - Sep 17 2014]
Covance Down 13.7% Since SmarTrend Downtrend Ca... [Published Comtex SmarTrend - Sep 17 2014]
Covance (CVD) Showing Bearish Technicals [Published MarketIntelligenceCenter.com - Sep 16 2014]
Covance (CVD) Showing Bullish Technicals With R... [Published MarketIntelligenceCenter.com - Sep 15 2014]
Covance (CVD) Showing Support Near $84.71 [Published MarketIntelligenceCenter.com - Sep 12 2014]
Covance (CVD) Trading Near $86.96 Resistance Level [Published MarketIntelligenceCenter.com - Sep 11 2014]
Insider Selling: Joseph L. Herring Unloads 32,2... [Published American Banking News - Forex - Sep 11 2014]
Covance (CVD) Trading Near $83.84 Support Level [Published MarketIntelligenceCenter.com - Sep 10 2014]
Covance Has Returned 13.9% Since SmarTrend Reco... [Published Comtex SmarTrend - Sep 09 2014]
Biggest Movers in Healthcare Stocks Now – ANAC ... [Published InvestorPlace.com - Sep 09 2014]
Covance (CVD) Showing Bearish Technicals With S... [Published MarketIntelligenceCenter.com - Sep 09 2014]
Potential Covance (CVD) Trade Has 2.38% Downsid... [Published MarketIntelligenceCenter.com - Sep 08 2014]
Covance To Present At The Morgan Stanley Global... [Published Stock Nod - Sep 07 2014]
Covance : To Present At The Morgan Stanley Glob... [Published 4 Traders - Sep 07 2014]
Covance To Present At The Morgan Stanley Global... [Published PR Newswire: Health - Sep 07 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Covance (CVD) Showing Bearish Technicals [Published MarketIntelligenceCenter.com - 6 hours ago]
Covance Inc (CVD) presents a trading opportunity that offers a 7% return in just 53 days.A covered call on Covance at the $85.00 level expiring on Nov. '14 offers an assigned return rate of 7% or 48.20% annualized. This trade offers 1.30% downside protection, ...
Covance (CVD) Showing Bearish Technicals With S... [Published MarketIntelligenceCenter.com - Sep 29 2014]
Covance Inc (CVD) traded between $81.17 and $83.14 before closing at $81.40 Friday and presents some attractive trading opportunities today. MarketIntelligenceCenter.com’s patented algorithms selected a Nov. '14 $85.00 covered call for a net debit of ...
Covance (CVD) Trading Near $81.68 Support Level [Published MarketIntelligenceCenter.com - Sep 26 2014]
After Thursday’s trading in Covance Inc (CVD) the option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center uncovered a trade that offers a 4.69% return, or 30.05% annualized (for comparison purposes only), ...
Covance (CVD) Trading Near $84.72 Resistance Level [Published MarketIntelligenceCenter.com - Sep 25 2014]
MarketIntelligenceCenter.com's patented trade-picking algorithms have identified an attractive covered-call trade on Covance Inc (CVD). Look at the Nov. '14 $85.00 covered call for a net debit in the $81.96 area. This trade has a duration of 58 days. ...
Covance (CVD) Showing Bearish Technicals With R... [Published MarketIntelligenceCenter.com - Sep 24 2014]
After closing Tuesday at $83.56, Covance Inc (CVD) presents an attractive opportunity to get a 4.80% return in just 59 days, which is an annualized return of 29.67% (for comparison purposes only). To enter this trade, sell one Nov. '14 $85.00 call for ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
The National Association of Free and Charitable... [Published GlobeNewswire: Advertising News - Aug 28 2014]
Financial Results, Investor Meeting Schedule, D... [Published Financial Services - Jul 30 2014]
New Laws, Pricing of Offering, Recognitions, Do... [Published Financial Services - Jun 30 2014]
Strategic Collaborations and Expanded Repurchas... [Published Financial Services - Jun 10 2014]
Covance To Present At The William Blair 34th An... [Published Financial Services - Jun 09 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.